Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yonghao Zhan

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Frontiers in Molecular Biosciences|September 27, 2021
Editorial: Engineering Signal Sensors Based on Reprogrammed CRISPR TechnologiesYuchen Liu, Tao Xu, Yonghao Zhan
Cell Discovery|March 15, 2022
CRISPR signal conductor 2.0 for redirecting cellular information flowYonghao Zhan, Aolin Li, Congcong Cao, et al.
Cellular & Molecular Biology Letters|April 12, 2024
CRISPR-Cas9 applications in T cells and adoptive T cell therapiesXiaoying Chen, Shuhan Zhong, Yonghao Zhan, et al.
Genome Biology|January 17, 2023
Enhanced RNA knockdown efficiency with engineered fusion guide RNAs that function with both CRISPR-CasRx and hammerhead ribozymeYonghao Zhan, Congcong Cao, Aolin Li, et al.
Discover Oncology|May 19, 2025
Current trends and landscape of drug resistance in renal cell carcinoma: a bibliometric analysisKenan Zhang, Shixu Chen, Zhenzhen Zhou, et al.
Environmental Pollution (Barking, Essex : 1987)|July 5, 2025
Multimodal detection and analysis of microplastics in human clear cell renal cell carcinomaKenan Zhang, Shuanbao Yu, Shixu Chen, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 18, 2020
Long non-coding RNA CASC9 promotes tumor growth and metastasis via modulating FZD6/Wnt/β-catenin signaling pathway in bladder cancerYonghao Zhan, Lianghao Zhang, Shuanbao Yu, et al.
Frontiers in Oncology|February 8, 2021
Identification of Immune-Related lncRNA Signature to Predict Prognosis and Immunotherapeutic Efficiency in Bladder CancerLianghao Zhang, Longqing Li, Yonghao Zhan, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 2, 2025
Exosome-transmitted LUCAT1 promotes stemness transformation and chemoresistance in bladder cancer by binding to IGF2BP2Yonghao Zhan, Zhenzhen Zhou, Zhaowei Zhu, et al.
Clinical and Translational Medicine|August 21, 2022
CircOMA1 promotes tumour growth and metastasis of bladder cancer by modulating IGF-IR/MAPK/EMT pathwayLianghao Zhang, Yonghao Zhan, Longqing Li, et al.
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Frontiers in Molecular Biosciences|September 27, 2021
Editorial: Engineering Signal Sensors Based on Reprogrammed CRISPR TechnologiesYuchen Liu, Tao Xu, Yonghao Zhan
Cell Discovery|March 15, 2022
CRISPR signal conductor 2.0 for redirecting cellular information flowYonghao Zhan, Aolin Li, Congcong Cao, et al.
Cellular & Molecular Biology Letters|April 12, 2024
CRISPR-Cas9 applications in T cells and adoptive T cell therapiesXiaoying Chen, Shuhan Zhong, Yonghao Zhan, et al.
Genome Biology|January 17, 2023
Enhanced RNA knockdown efficiency with engineered fusion guide RNAs that function with both CRISPR-CasRx and hammerhead ribozymeYonghao Zhan, Congcong Cao, Aolin Li, et al.
Discover Oncology|May 19, 2025
Current trends and landscape of drug resistance in renal cell carcinoma: a bibliometric analysisKenan Zhang, Shixu Chen, Zhenzhen Zhou, et al.
Environmental Pollution (Barking, Essex : 1987)|July 5, 2025
Multimodal detection and analysis of microplastics in human clear cell renal cell carcinomaKenan Zhang, Shuanbao Yu, Shixu Chen, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 18, 2020
Long non-coding RNA CASC9 promotes tumor growth and metastasis via modulating FZD6/Wnt/β-catenin signaling pathway in bladder cancerYonghao Zhan, Lianghao Zhang, Shuanbao Yu, et al.
Frontiers in Oncology|February 8, 2021
Identification of Immune-Related lncRNA Signature to Predict Prognosis and Immunotherapeutic Efficiency in Bladder CancerLianghao Zhang, Longqing Li, Yonghao Zhan, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 2, 2025
Exosome-transmitted LUCAT1 promotes stemness transformation and chemoresistance in bladder cancer by binding to IGF2BP2Yonghao Zhan, Zhenzhen Zhou, Zhaowei Zhu, et al.
Clinical and Translational Medicine|August 21, 2022
CircOMA1 promotes tumour growth and metastasis of bladder cancer by modulating IGF-IR/MAPK/EMT pathwayLianghao Zhang, Yonghao Zhan, Longqing Li, et al.
Pageof 7